Alopecia Areata Overview - Baldness (Alopecia) - Dermatology Channel Alopecia areata is an autoimmune disease wherein the immune system attacks the hair follicles. The follicles become very small, hair production slows, and there is a lack of http://www.dermatologychannel.net/alopecia/areata.shtml
Extractions: Home Health Topics Health Reports Learning Centers ... Baldness (Alopecia) Alopecia Areata Overview Share: Send to a Friend Print Alopecia areata is a common type of hair loss that affects approximately 2% of the population, or more than 4 million people in the United States. It affects both men and women, predominately children and young adults, but it can also develop in older adults. It usually starts out as smooth, small, round or oval patches of baldness that rapidly form on one side of the head. The edges of the patches are usually studded with "exclamation point hairs." Erythema (inflammatory redness of the skin) may be present early on. For most people, the hair regrows within a year without treatment. The longer the time before hair regrows, the less likely it will regrow without treatment. Sometimes, the hair loss is permanent. Alopecia areata is an autoimmune disease (i.e., the immune system attacks the hair follicles). The follicles become very small, hair production slows, and there is a lack of visible hair for months or years. Yet, the follicles usually resume normal hair growth within a year. Attacks of alopecia areata are often associated with other autoimmune conditions such as lupus and allergies. In about 20% of cases, the patient is related to someone who has or has had the disease.
AccessMedicine | Alopecia Areata Alopecia areata Quick Answers B Baldness Key Features General Considerations; Alopecia Areata Dermatology Chapter 86. Hair Growth Disorders http://www.accessmedicine.com/search/searchAMResult.aspx?rootterm=alopecia areat
Extractions: systemic corticosteroids for alopecia areata Home Forums Links Contact Us ... Systemic corticosteroids for alopecia areata references Systemic corticosteroids for alopecia areata Although research over the last few years has yielded valuable data on the etiology and pathophysiology of the insidious form of hair loss in alopecia areata, the exact pathogenesis of the disease remains obscure, with the result that there is neither a permanent cure for alopecia areata nor a universally proven therapy for inducing remission. Early intervention is crucial, and most patients can be offered hope and support to help them cope with the months of treatment usually needed to achieve reduction in disease symptoms. Current prevalent therapies used in the treatment of alopecia areata are predominantly immunomodulating in nature, with Corticosteroids being the most popular form of treatment for patchy alopecia areata. There is supporting evidence to substantiate the theory that alopecia areata is a T-cell mediated response, and corticosteroids are known to exert a strong inhibitory effect on the activation of T lymphocytes. Corticosteroids also reduce inflammation and pain, and can be administered in four different ways; topically as a cream or lotion, intralesional as local injections into the bald patches, and systemically either as injections into a muscle or taken orally. Each of these methods of administration varies in their potency, and also bears different rates of success and side effects.
Extractions: You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better. Select Journal or Resource JAMA Archives of Dermatology Facial Plastic Surgery Family Medicine (1992-2000) General Psychiatry Internal Medicine Neurology Neurology and Psychiatry (1919-1959) Ophthalmology Surgery Calendar of Events JAMA Career Center For The Media JAMAevidence AMA Manual of Style Peer Review Congress ABOUT ARCHIVES Search: Advanced Search Welcome My Account E-mail Alerts Sign In Information for: Authors/Reviewers Readers Institutions/Libraries Subscription Agents News Media Job Seekers/Employers Advertisers Vol. 66 No. 6, December 1952 Online Only Online First Table of
FreeMD® Alopecia Areata Treatment: Specialist Physicians from the following specialties evaluate and treat alopecia areata * Dermatology http://www.freemd.com/alopecia-areata/treatment-specialist.htm
Extractions: COSMETIC SERVICES SURGICAL SERVICES PATIENT FORMS INSURANCE THE DOCTORS JOBS ... CONTACT US Alopecia Areata This condition is an autoimmune disease that causes hair loss, often in small round patches on the scalp. About 2% of the population will suffer from alopecia areata at some point, although it usually begins in childhood. With this condition, the immune system mistakenly attacks the hair follicles from which hair grows. Experts believe some people's genes make them more susceptible to this condition, but environmental triggers such as oral contraceptives or stress may also play a role. Treatments for this condition include cortisone injections, pills, topical creams and immunotherapy. These treatments may promote hair growth, but do not treat the underlying cause of the condition. We are committed to providing you with the best information possible. Â See the video below and schedule your appointment today for a complete evaluation of your condition. Â You may also print this information.Â
Alopecia Universalis With Twenty-nail Dystrophy (trachyonychia) A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006; 212361 http://dermatology.cdlib.org/145/nyu/cases/051507_8.html
Extractions: Department of Dermatology, New York University A 43-year-old man presented with long-standing trachyonychia of all 20 nails, noted worsening of his nail disease after the onset of alopecia universalis 18 months ago prior to presentation. Trachyonychia can be associated with alopecia universalis although the treatment strategies of both conditions differ. The principle of treating trachyonychia may involve regulating the differentiation of keratinocytes and/or reducing inflammation in the nail fold or nail matrix. The treatment of alopecia universalis involves immunomodulation. A 43-year-old man initially presented to the NYU Dermatology Associates in April, 2007, for evaluation of nail ridges. The nail ridges have been present for 10 years but have worsened 18 months ago after the onset of hair loss over his entire body. He used fluocinonide lotion previously for the hair loss. Past medical history and a review of systems were noncontributory. His children have eczema. He takes no medications.
Extractions: corticosteroid treatment of alopecia areata overview Home Forums Links Contact Us ... Corticosteroids for alopecia areata references Topical corticosteroids for alopecia areata Corticosteroids are probably the most popular form of treatment for patchy alopecia areata. Steroids can be administered in four different ways; topically as a cream or lotion, intralesionally as local injections into the bald patches, and systemically either as injections into a muscle or taken orally. These different methods of application vary in their potency. Note that the corticosteroids used are not anabolic steroids! Synthetic corticosteroids are mimics of hormones made by the adrenal glands and these steroidal hormones have a very different set of actions compared to anabolic steroids. Topical creams are available with several different commercial trade names and with different concentrations of steroids from 0.05 to 0.2%. They are applied only to the regions of hair loss and they are the mildest form of steroid treatment. Typically, dermatologists will try a milder form of treatment before attempting to use stronger forms with their greater potential for side effects. Response to topical steroids in therapeutic trials has been mixed. Reports of nearly 100% response for prepubertal children have been reported alongside a response rate of just 33% in adults in a double blind study (Pascher 1970). Response to corticosteroids is more likely the shorter the time period alopecia areata has been present. Hair regrowth is not always immediate with reports of delay up to 3 months before hair regrowth was noticeable.
ALOPECIA AREATA alopecia areata dermatology lecture notes debabrata bandyopadhyay, professor head, dept. of dermatology, r. g. kar medical college, calcutta, india http://dermind.tripod.com/areata.htm
Extractions: R. G. KAR MEDICAL COLLEGE, CALCUTTA, INDIA Alopecia areata is a common disorder characterized by localized, complete loss of hairs in round or oval patches without any signs of inflammation. Believed to be an autoimmune disorder, AA may be associated with other autoimmune diseases. While spontaneous regrowth may occur in a proportion of cases, AA may be a long-standing and recurrent cause of hair loss that is associated with significant psychological distress. ETIOLOGY AND PATHOGENESIS The cause of AA is obscure. Immune-mediated injury induced by possible infective, chemical, of neuropeptide stimulant is believed to cause damage to hair follicles. There is an increased incidence of autoantibodies directed against gastric parietal cells, thyroid, smooth muscles etc in AA. A number of diseases are significantly associated with AA.
Tratamiento De La Alopecia Areata S. ahin, B. Yal n, A. Karaduman PUVA Treatment for Alopecia areata Dermatology 19731998, 245247. Twenty-four patients (15 female and 9 male) suffering from extensive AA for http://www.uv.es/~vicalegr/TXindex/txareata.html
Extractions: Tratamiento de la Alopecia areata Ciclosporina Antralina Minoxidil y antralina Zinc en la Alopecia areata ... The use of methotrexate Gupta AK. Oral cyclosporine for the treatment of alopecia areata. JAAD 1990 22:242-50 we treated six patients with oral cyclosporine 6 mgr/kg/dia/`12w. three had alopecia universalis one had alopecia totalis and two had patchy alopecia areata of the scalp. Hair re growth in the scalp occurred within the second and four weeks of therapy, followed by hair re growth of the face and chest(on male patients), pubic area, extremities, and axillae, overall the best response was the scalp. Cosmetically acceptable hair re growth occurred in three of the six patients Baseline perdida de pelo semana 12 semana 14 Treatment of resistant alopecia areata. Fridler VC et al. Arch Dermatol 1990, 126:756-9.
Extractions: Login Search This journal All of Nature.com Advanced search Journal home Archive Original Articles Full text Journal of Investigative Dermatology Symposium Proceedings Vera H Price Department of Dermatology, University of California, San Francisco, California, USA Correspondence: Vera H. Price, Department of Dermatology, University of California, San Francisco, 350 Parnassus Avenue, Suite 404, San Francisco, CA 94117, USA. Email: vhprice@orca.ucsf.edu Received 30 December 2002; Accepted 13 February 2003. Top of page , and tumor necrosis factor- . Like other diseases with a strong autoimmune component, alopecia areata has associated with it specific human leukocyte antigens, which determine susceptibility, severity, chronicity, and resistance. New topical immunomodulating drugs and biologic therapies that have been developed, or that are in development, for the treatment of other immune-mediated inflammatory skin diseases will likely be effective in alopecia areata as well. The present discussion addresses the treatment of alopecia areata within the framework of these new modalities. lymphocytes, macrophages, Langerhans cells, immunomodulating drugs, biologic therapies
EMedicine Search Alopecia Areata (Dermatology) Alopecia areata is a recurrent nonscarring type of hair loss that can affect any hairbearing area. Clinically, alopecia areata can manifest many http://search.medscape.com/emedicine-search?queryText=Hair loss
Jo O Mauricio Martins Articles in Scholarly Journals Incomplete List Vitiligo after Diphencyprone for Alopecia Areata Dermatology Research and Practice, vol. 2010, no. 8122, Article ID 171265, 2 pages http://www.hindawi.com/89160873.html
Extractions: search： see more disease documents Decreased Serum Ferritin is Associated With Alopecia in Women (AAT/U) treated at the University of Pennsylvania hair and scalp clinic. ... The diagnoses of AA, AAT, and AAU were also made by history ... ... Primary Cicatricial Alopecia: Clinical Features and Management disorders such as pemphigus vulgaris. In all cases of suspected cicatricial ... and acne keloidalis. These diseases. can usually be distinguished clinical ... ... Alopecia Areata ... thyroid disease, systemic lupus erythematosus, pernicious anemia, or Addison's disease. People who ... Addison's disease—a condition that occurs when the adren ... ... Primary Cicatricial Alopecia: Clinical Features and Management erythematosus, folliculitis decalvans, and acne keloidalis. These diseases ... Folliculitis decalvans. Source: Photo courtesy of Vera Price, MD. ... ... MVP/Preferred Care BENEFIT INTERPRETATION Alopecia/Wigs /Scalp Prosthesis MVP/Preferred Care BENEFIT INTERPRETATION MANUAL Alopecia/Wigs /Scalp ... Keratin 17 null mice exhibit age- and strain-dependent alopecia Kevin M. McGowan, Xuemei Tong, Emma Colucci-Guyon, Francina Langa, Charles Babinet and Pierre A. ... are related to ectodermal dysplasias (Feinstein et al. 1988) ... ... Clinical Approach to the Patient With Alopecia Hair loss, or alopecia, is a common patient complaint and a ... syndrome, ectodermal dysplasias). 25. Loose anagen hair syndrome is predominantly a disease of ... ...
